Cargando…
The Anti-inflammatory Compound Candesartan Cilexetil Improves Neurological Outcomes in a Mouse Model of Neonatal Hypoxia
Recent studies suggest that mild hypoxia-induced neonatal seizures can trigger an acute neuroinflammatory response leading to long-lasting changes in brain excitability along with associated cognitive and behavioral deficits. The cellular elements and signaling pathways underlying neuroinflammation...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667988/ https://www.ncbi.nlm.nih.gov/pubmed/31396238 http://dx.doi.org/10.3389/fimmu.2019.01752 |
_version_ | 1783440134550585344 |
---|---|
author | Quinlan, Sean Merino-Serrais, Paula Di Grande, Alessandra Dussmann, Heiko Prehn, Jochen H. M. Ní Chonghaile, Tríona Henshall, David C. Jimenez-Mateos, Eva M. |
author_facet | Quinlan, Sean Merino-Serrais, Paula Di Grande, Alessandra Dussmann, Heiko Prehn, Jochen H. M. Ní Chonghaile, Tríona Henshall, David C. Jimenez-Mateos, Eva M. |
author_sort | Quinlan, Sean |
collection | PubMed |
description | Recent studies suggest that mild hypoxia-induced neonatal seizures can trigger an acute neuroinflammatory response leading to long-lasting changes in brain excitability along with associated cognitive and behavioral deficits. The cellular elements and signaling pathways underlying neuroinflammation in this setting remain incompletely understood but could yield novel therapeutic targets. Here we show that brief global hypoxia-induced neonatal seizures in mice result in transient cytokine production, a selective expansion of microglia and long-lasting changes to the neuronal structure of pyramidal neurons in the hippocampus. Treatment of neonatal mice after hypoxia-seizures with the novel anti-inflammatory compound candesartan cilexetil suppressed acute seizure-damage and mitigated later-life aggravated seizure responses and hippocampus-dependent learning deficits. Together, these findings improve our understanding of the effects of neonatal seizures and identify potentially novel treatments to protect against short and long-lasting harmful effects. |
format | Online Article Text |
id | pubmed-6667988 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-66679882019-08-08 The Anti-inflammatory Compound Candesartan Cilexetil Improves Neurological Outcomes in a Mouse Model of Neonatal Hypoxia Quinlan, Sean Merino-Serrais, Paula Di Grande, Alessandra Dussmann, Heiko Prehn, Jochen H. M. Ní Chonghaile, Tríona Henshall, David C. Jimenez-Mateos, Eva M. Front Immunol Immunology Recent studies suggest that mild hypoxia-induced neonatal seizures can trigger an acute neuroinflammatory response leading to long-lasting changes in brain excitability along with associated cognitive and behavioral deficits. The cellular elements and signaling pathways underlying neuroinflammation in this setting remain incompletely understood but could yield novel therapeutic targets. Here we show that brief global hypoxia-induced neonatal seizures in mice result in transient cytokine production, a selective expansion of microglia and long-lasting changes to the neuronal structure of pyramidal neurons in the hippocampus. Treatment of neonatal mice after hypoxia-seizures with the novel anti-inflammatory compound candesartan cilexetil suppressed acute seizure-damage and mitigated later-life aggravated seizure responses and hippocampus-dependent learning deficits. Together, these findings improve our understanding of the effects of neonatal seizures and identify potentially novel treatments to protect against short and long-lasting harmful effects. Frontiers Media S.A. 2019-07-24 /pmc/articles/PMC6667988/ /pubmed/31396238 http://dx.doi.org/10.3389/fimmu.2019.01752 Text en Copyright © 2019 Quinlan, Merino-Serrais, Di Grande, Dussmann, Prehn, Ní Chonghaile, Henshall and Jimenez-Mateos. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Quinlan, Sean Merino-Serrais, Paula Di Grande, Alessandra Dussmann, Heiko Prehn, Jochen H. M. Ní Chonghaile, Tríona Henshall, David C. Jimenez-Mateos, Eva M. The Anti-inflammatory Compound Candesartan Cilexetil Improves Neurological Outcomes in a Mouse Model of Neonatal Hypoxia |
title | The Anti-inflammatory Compound Candesartan Cilexetil Improves Neurological Outcomes in a Mouse Model of Neonatal Hypoxia |
title_full | The Anti-inflammatory Compound Candesartan Cilexetil Improves Neurological Outcomes in a Mouse Model of Neonatal Hypoxia |
title_fullStr | The Anti-inflammatory Compound Candesartan Cilexetil Improves Neurological Outcomes in a Mouse Model of Neonatal Hypoxia |
title_full_unstemmed | The Anti-inflammatory Compound Candesartan Cilexetil Improves Neurological Outcomes in a Mouse Model of Neonatal Hypoxia |
title_short | The Anti-inflammatory Compound Candesartan Cilexetil Improves Neurological Outcomes in a Mouse Model of Neonatal Hypoxia |
title_sort | anti-inflammatory compound candesartan cilexetil improves neurological outcomes in a mouse model of neonatal hypoxia |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667988/ https://www.ncbi.nlm.nih.gov/pubmed/31396238 http://dx.doi.org/10.3389/fimmu.2019.01752 |
work_keys_str_mv | AT quinlansean theantiinflammatorycompoundcandesartancilexetilimprovesneurologicaloutcomesinamousemodelofneonatalhypoxia AT merinoserraispaula theantiinflammatorycompoundcandesartancilexetilimprovesneurologicaloutcomesinamousemodelofneonatalhypoxia AT digrandealessandra theantiinflammatorycompoundcandesartancilexetilimprovesneurologicaloutcomesinamousemodelofneonatalhypoxia AT dussmannheiko theantiinflammatorycompoundcandesartancilexetilimprovesneurologicaloutcomesinamousemodelofneonatalhypoxia AT prehnjochenhm theantiinflammatorycompoundcandesartancilexetilimprovesneurologicaloutcomesinamousemodelofneonatalhypoxia AT nichonghailetriona theantiinflammatorycompoundcandesartancilexetilimprovesneurologicaloutcomesinamousemodelofneonatalhypoxia AT henshalldavidc theantiinflammatorycompoundcandesartancilexetilimprovesneurologicaloutcomesinamousemodelofneonatalhypoxia AT jimenezmateosevam theantiinflammatorycompoundcandesartancilexetilimprovesneurologicaloutcomesinamousemodelofneonatalhypoxia AT quinlansean antiinflammatorycompoundcandesartancilexetilimprovesneurologicaloutcomesinamousemodelofneonatalhypoxia AT merinoserraispaula antiinflammatorycompoundcandesartancilexetilimprovesneurologicaloutcomesinamousemodelofneonatalhypoxia AT digrandealessandra antiinflammatorycompoundcandesartancilexetilimprovesneurologicaloutcomesinamousemodelofneonatalhypoxia AT dussmannheiko antiinflammatorycompoundcandesartancilexetilimprovesneurologicaloutcomesinamousemodelofneonatalhypoxia AT prehnjochenhm antiinflammatorycompoundcandesartancilexetilimprovesneurologicaloutcomesinamousemodelofneonatalhypoxia AT nichonghailetriona antiinflammatorycompoundcandesartancilexetilimprovesneurologicaloutcomesinamousemodelofneonatalhypoxia AT henshalldavidc antiinflammatorycompoundcandesartancilexetilimprovesneurologicaloutcomesinamousemodelofneonatalhypoxia AT jimenezmateosevam antiinflammatorycompoundcandesartancilexetilimprovesneurologicaloutcomesinamousemodelofneonatalhypoxia |